With a longer follow-up period and more enrollment for the CRC cohort, we demonstrated patients with CSF1R c.1085 A_G had a better overall survival compared to patients with CSF1R genotype A_A in this study, consistent with our prior findings. This evidence concerns the gene CSF1R and colorectal carcinoma.